SEC Info - Cytrx Corp - ‘10-K’ for 12/31/19

SEC Info℠

Home

Help

Please Sign In

Cytrx Corp – ‘10-K’ for 12/31/19 – ‘EX-101.CAL’

On: Friday, 3/27/20, at 6:21am ET · For: 12/31/19 · Accession #: 1493152-20-4848 · File #: 0-15327

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/27/20  Cytrx Corp                        10-K       12/31/19   71:12M                                    M2 Compliance/FA

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    699K 
 2: EX-10.4.3   Material Contract                                   HTML     23K 
 3: EX-23.1     Consent of Experts or Counsel                       HTML     22K 
 4: EX-23.2     Consent of Experts or Counsel                       HTML     23K 
 5: EX-31.1     Certification -- §302 - SOA'02                      HTML     26K 
 6: EX-31.2     Certification -- §302 - SOA'02                      HTML     26K 
 7: EX-32.1     Certification -- §906 - SOA'02                      HTML     23K 
 8: EX-32.2     Certification -- §906 - SOA'02                      HTML     23K 
25: R1          Document and Entity Information                     HTML     57K 
50: R2          Consolidated Balance Sheets                         HTML     93K 
64: R3          Consolidated Balance Sheets (Parenthetical)         HTML     50K 
38: R4          Consolidated Statements of Operations               HTML     83K 
26: R5          Consolidated Statements of Stockholders' Equity     HTML     49K 
51: R6          Consolidated Statements of Cash Flows               HTML    116K 
65: R7          Nature of Business                                  HTML     39K 
35: R8          Summary of Significant Accounting Policies          HTML     53K 
28: R9          Discontinued Operations                             HTML     36K 
52: R10         Foreign Currency Remeasurement                      HTML     25K 
69: R11         Equipment and Furnishings                           HTML     27K 
32: R12         Accrued Expenses and Other Current Liabilities      HTML     28K 
22: R13         Leases                                              HTML     31K 
53: R14         Commitments and Contingencies                       HTML     34K 
70: R15         Equity Transactions                                 HTML     24K 
33: R16         Stock Options and Equity-Classified Warrants        HTML     94K 
23: R17         Stockholder Protection Rights Plan                  HTML     32K 
54: R18         Income Taxes                                        HTML     42K 
68: R19         Subsequent Events                                   HTML     25K 
46: R20         Summary of Significant Accounting Policies          HTML     95K 
                (Policies)                                                       
19: R21         Summary of Significant Accounting Policies          HTML     29K 
                (Tables)                                                         
58: R22         Discontinued Operations (Tables)                    HTML     39K 
62: R23         Equipment and Furnishings (Tables)                  HTML     27K 
47: R24         Accrued Expenses and Other Current Liabilities      HTML     27K 
                (Tables)                                                         
20: R25         Leases (Tables)                                     HTML     26K 
59: R26         Commitments and Contingencies (Tables)              HTML     27K 
63: R27         Stock Options and Equity-Classified Warrants        HTML    102K 
                (Tables)                                                         
45: R28         Income Taxes (Tables)                               HTML     39K 
21: R29         Nature of Business (Details Narrative)              HTML     54K 
29: R30         Summary of Significant Accounting Policies          HTML     54K 
                (Details Narrative)                                              
36: R31         Summary of Significant Accounting Policies -        HTML     28K 
                Schedule of Fair Value Measurements by Level for                 
                Assets and Liabilities Measured at Fair Value on a               
                Recurring Basis (Details)                                        
67: R32         Discontinued Operations (Details Narrative)         HTML     46K 
49: R33         Discontinued Operations - Schedule of Discontinued  HTML     66K 
                Operations (Details)                                             
27: R34         Foreign Currency Remeasurement (Details Narrative)  HTML     24K 
34: R35         Equipment and Furnishings (Details Narrative)       HTML     24K 
66: R36         Equipment and Furnishings - Schedule of Equipment   HTML     31K 
                and Furnishings (Details)                                        
48: R37         Accrued Expenses and Other Current Liabilities -    HTML     38K 
                Schedule of Accrued Expenses and Other Current                   
                Liabilities (Details)                                            
24: R38         Leases (Details Narrative)                          HTML     32K 
37: R39         Leases - Schedule of Rent Expense and Supplemental  HTML     31K 
                Cash Flow Information Related to Leases (Details)                
17: R40         Commitments and Contingencies (Details Narrative)   HTML     31K 
43: R41         Commitments and Contingencies - Schedule of         HTML     42K 
                Current Contractual Obligations (Details)                        
61: R42         Equity Transactions (Details Narrative)             HTML     29K 
57: R43         Stock Options and Equity-Classified Warrants        HTML     60K 
                (Details Narrative)                                              
16: R44         Stock Options and Equity-Classified Warrants -      HTML     35K 
                Schedule of Share-based Payment Award, Fair Value                
                of the Stock Options Granted, Assumptions                        
                (Details)                                                        
42: R45         Stock Options and Equity-Classified Warrants -      HTML     68K 
                Schedule of Share-based Compensation, Stock                      
                Options, Activity (Details)                                      
60: R46         Stock Options and Equity-Classified Warrants -      HTML     60K 
                Schedule of Ranges of Stock Options (Details)                    
56: R47         Stock Options and Equity-Classified Warrants -      HTML     30K 
                Schedule of Total Stock-based Compensation Expense               
                from Stock Options (Details)                                     
15: R48         Stock Options and Equity-Classified Warrants -      HTML     52K 
                Schedule of Warrants Activity and Related                        
                Information (Details)                                            
44: R49         Stock Options and Equity-Classified Warrants -      HTML     61K 
                Schedule of Ranges of Warrants (Details)                         
39: R50         Stockholder Protection Rights Plan (Details         HTML     39K 
                Narrative)                                                       
30: R51         Income Taxes (Details Narrative)                    HTML     45K 
55: R52         Income Taxes - Schedule of Deferred Tax Assets and  HTML     43K 
                Liabilities (Details)                                            
71: R53         Income Taxes - Schedule of Effective Income Tax     HTML     54K 
                Rate Reconciliation (Details)                                    
40: R54         Subsequent Events (Details Narrative)               HTML     36K 
18: XML         IDEA XML File -- Filing Summary                      XML    122K 
41: EXCEL       IDEA Workbook of Financial Reports                  XLSX     66K 
 9: EX-101.INS  XBRL Instance -- cytr-20191231                       XML   1.03M 
11: EX-101.CAL  XBRL Calculations -- cytr-20191231_cal               XML    152K 
12: EX-101.DEF  XBRL Definitions -- cytr-20191231_def                XML    487K 
13: EX-101.LAB  XBRL Labels -- cytr-20191231_lab                     XML    900K 
14: EX-101.PRE  XBRL Presentations -- cytr-20191231_pre              XML    676K 
10: EX-101.SCH  XBRL Schema -- cytr-20191231                         XSD    148K 
31: ZIP         XBRL Zipped Folder -- 0001493152-20-004848-xbrl      Zip    116K

‘EX-101.CAL’ — XBRL Calculations — cytr-20191231_cal

This Exhibit is an XBRL XML File.

<?xml version="1.0" standalone="no" encoding="windows-1252"?>

<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">

<link:roleRef roleURI="http://cytrx.com/role/DocumentAndEntityInformation" xlink:href="cytr-20191231.xsd#DocumentAndEntityInformation" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/BalanceSheets" xlink:href="cytr-20191231.xsd#BalanceSheets" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/BalanceSheetsParenthetical" xlink:href="cytr-20191231.xsd#BalanceSheetsParenthetical" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/StatementsOfOperations" xlink:href="cytr-20191231.xsd#StatementsOfOperations" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/StatementsOfStockholdersEquity" xlink:href="cytr-20191231.xsd#StatementsOfStockholdersEquity" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/StatementsOfCashFlows" xlink:href="cytr-20191231.xsd#StatementsOfCashFlows" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/NatureOfBusiness" xlink:href="cytr-20191231.xsd#NatureOfBusiness" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/SummaryOfSignificantAccountingPolicies" xlink:href="cytr-20191231.xsd#SummaryOfSignificantAccountingPolicies" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/DiscontinuedOperations" xlink:href="cytr-20191231.xsd#DiscontinuedOperations" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/ForeignCurrencyRemeasurement" xlink:href="cytr-20191231.xsd#ForeignCurrencyRemeasurement" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/EquipmentAndFurnishings" xlink:href="cytr-20191231.xsd#EquipmentAndFurnishings" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:href="cytr-20191231.xsd#AccruedExpensesAndOtherCurrentLiabilities" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/Leases" xlink:href="cytr-20191231.xsd#Leases" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/CommitmentsAndContingencies" xlink:href="cytr-20191231.xsd#CommitmentsAndContingencies" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/EquityTransactions" xlink:href="cytr-20191231.xsd#EquityTransactions" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants" xlink:href="cytr-20191231.xsd#StockOptionsAndEquity-classifiedWarrants" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/StockholderProtectionRightsPlan" xlink:href="cytr-20191231.xsd#StockholderProtectionRightsPlan" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/IncomeTaxes" xlink:href="cytr-20191231.xsd#IncomeTaxes" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/SubsequentEvents" xlink:href="cytr-20191231.xsd#SubsequentEvents" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:href="cytr-20191231.xsd#SummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:href="cytr-20191231.xsd#SummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/DiscontinuedOperationsTables" xlink:href="cytr-20191231.xsd#DiscontinuedOperationsTables" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/EquipmentAndFurnishingsTables" xlink:href="cytr-20191231.xsd#EquipmentAndFurnishingsTables" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:href="cytr-20191231.xsd#AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/LeasesTables" xlink:href="cytr-20191231.xsd#LeasesTables" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/CommitmentsAndContingenciesTables" xlink:href="cytr-20191231.xsd#CommitmentsAndContingenciesTables" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrantsTables" xlink:href="cytr-20191231.xsd#StockOptionsAndEquity-classifiedWarrantsTables" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/IncomeTaxesTables" xlink:href="cytr-20191231.xsd#IncomeTaxesTables" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/NatureOfBusinessDetailsNarrative" xlink:href="cytr-20191231.xsd#NatureOfBusinessDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:href="cytr-20191231.xsd#SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueMeasurementsByLevelForAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="cytr-20191231.xsd#SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueMeasurementsByLevelForAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/DiscontinuedOperationsDetailsNarrative" xlink:href="cytr-20191231.xsd#DiscontinuedOperationsDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/DiscontinuedOperations-ScheduleOfDiscontinuedOperationsDetails" xlink:href="cytr-20191231.xsd#DiscontinuedOperations-ScheduleOfDiscontinuedOperationsDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/ForeignCurrencyRemeasurementDetailsNarrative" xlink:href="cytr-20191231.xsd#ForeignCurrencyRemeasurementDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/EquipmentAndFurnishingsDetailsNarrative" xlink:href="cytr-20191231.xsd#EquipmentAndFurnishingsDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/EquipmentAndFurnishings-ScheduleOfEquipmentAndFurnishingsDetails" xlink:href="cytr-20191231.xsd#EquipmentAndFurnishings-ScheduleOfEquipmentAndFurnishingsDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/AccruedExpensesAndOtherCurrentLiabilities-ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="cytr-20191231.xsd#AccruedExpensesAndOtherCurrentLiabilities-ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/LeasesDetailsNarrative" xlink:href="cytr-20191231.xsd#LeasesDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/Leases-ScheduleOfRentExpenseAndSupplementalCashFlowInformationRelatedToLeasesDetails" xlink:href="cytr-20191231.xsd#Leases-ScheduleOfRentExpenseAndSupplementalCashFlowInformationRelatedToLeasesDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:href="cytr-20191231.xsd#CommitmentsAndContingenciesDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/CommitmentsAndContingencies-ScheduleOfCurrentContractualObligationsDetails" xlink:href="cytr-20191231.xsd#CommitmentsAndContingencies-ScheduleOfCurrentContractualObligationsDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/EquityTransactionsDetailsNarrative" xlink:href="cytr-20191231.xsd#EquityTransactionsDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrantsDetailsNarrative" xlink:href="cytr-20191231.xsd#StockOptionsAndEquity-classifiedWarrantsDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfShare-basedPaymentAwardFairValueOfStockOptionsGrantedAssumptionsDetails" xlink:href="cytr-20191231.xsd#StockOptionsAndEquity-classifiedWarrants-ScheduleOfShare-basedPaymentAwardFairValueOfStockOptionsGrantedAssumptionsDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfShare-basedCompensationStockOptionsActivityDetails" xlink:href="cytr-20191231.xsd#StockOptionsAndEquity-classifiedWarrants-ScheduleOfShare-basedCompensationStockOptionsActivityDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfRangesOfStockOptionsDetails" xlink:href="cytr-20191231.xsd#StockOptionsAndEquity-classifiedWarrants-ScheduleOfRangesOfStockOptionsDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfTotalStock-basedCompensationExpenseFromStockOptionsDetails" xlink:href="cytr-20191231.xsd#StockOptionsAndEquity-classifiedWarrants-ScheduleOfTotalStock-basedCompensationExpenseFromStockOptionsDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfWarrantsActivityAndRelatedInformationDetails" xlink:href="cytr-20191231.xsd#StockOptionsAndEquity-classifiedWarrants-ScheduleOfWarrantsActivityAndRelatedInformationDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfRangesOfWarrantsDetails" xlink:href="cytr-20191231.xsd#StockOptionsAndEquity-classifiedWarrants-ScheduleOfRangesOfWarrantsDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/StockholderProtectionRightsPlanDetailsNarrative" xlink:href="cytr-20191231.xsd#StockholderProtectionRightsPlanDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/IncomeTaxesDetailsNarrative" xlink:href="cytr-20191231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="cytr-20191231.xsd#IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:href="cytr-20191231.xsd#IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:type="simple"/>

<link:roleRef roleURI="http://cytrx.com/role/SubsequentEventsDetailsNarrative" xlink:href="cytr-20191231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/DocumentAndEntityInformation" xlink:title="00000001 - Document - Document and Entity Information"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ReceivablesNetCurrent" xlink:label="loc_us-gaapReceivablesNetCurrent"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapReceivablesNetCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:label="loc_us-gaapAssetsHeldForSaleNotPartOfDisposalGroupCurrent"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapAssetsHeldForSaleNotPartOfDisposalGroupCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="loc_us-gaapOtherAssetsNoncurrent"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOtherAssetsNoncurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AssetsHeldForSaleNotPartOfDisposalGroup" xlink:label="loc_us-gaapAssetsHeldForSaleNotPartOfDisposalGroup"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsHeldForSaleNotPartOfDisposalGroup" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:label="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapLiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="loc_us-gaapPreferredStockValue"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapPreferredStockValue" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="loc_us-gaapAdditionalPaidInCapital"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapital" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:label="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapRevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromContinuingOperations" xlink:label="loc_us-gaapIncomeLossFromContinuingOperations"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InterestExpense" xlink:label="loc_us-gaapInterestExpense"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapInterestExpense" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="loc_us-gaapOtherNonoperatingIncomeExpense"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapOtherNonoperatingIncomeExpense" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DerivativeGainLossOnDerivativeNet" xlink:label="loc_us-gaapDerivativeGainLossOnDerivativeNet"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="loc_us-gaapInvestmentIncomeInterest"/>

<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperations" xlink:to="loc_us-gaapInvestmentIncomeInterest" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:label="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" weight="1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/StatementsOfStockholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Stockholders' Equity"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity" xlink:type="arc" weight="1"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncomeLossFromContinuingOperations" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization" xlink:label="loc_us-gaapDepreciationDepletionAndAmortization"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapDepreciationDepletionAndAmortization" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GainLossOnDispositionOfAssets1" xlink:label="loc_us-gaapGainLossOnDispositionOfAssets1"/>

<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapGainLossOnDispositionOfAssets1" xlink:type="arc" weight="-1"/>

<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapDerivativeGainLossOnDerivativeNet" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_GoodwillImpairmentLoss" xlink:label="loc_us-gaapGoodwillImpairmentLoss"/>

<link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapGoodwillImpairmentLoss" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:label="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts"/>

<link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapAmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation"/>

<link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsReceivable"/>

<link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsReceivable" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>

<link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayable"/>

<link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayable" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets"/>

<link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInOtherOperatingAssets" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>

<link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivitiesContinuingOperations" xlink:to="loc_us-gaapIncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:label="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapCashProvidedByUsedInOperatingActivitiesDiscontinuedOperations" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities"/>

<link:loc xlink:type="locator" xlink:href="cytr-20191231.xsd#CYTR_PaymentsForProceedsFromSaleOfPropertyPlantAndEquipment" xlink:label="loc_CYTRPaymentsForProceedsFromSaleOfPropertyPlantAndEquipment"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_CYTRPaymentsForProceedsFromSaleOfPropertyPlantAndEquipment" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="loc_us-gaapProceedsFromIssuanceInitialPublicOffering"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceInitialPublicOffering" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="loc_us-gaapRepaymentsOfLongTermDebt"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapRepaymentsOfLongTermDebt" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PaymentsOfLoanCosts" xlink:label="loc_us-gaapPaymentsOfLoanCosts"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapPaymentsOfLoanCosts" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/NatureOfBusiness" xlink:title="00000007 - Disclosure - Nature of Business"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/SummaryOfSignificantAccountingPolicies" xlink:title="00000008 - Disclosure - Summary of Significant Accounting Policies"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/DiscontinuedOperations" xlink:title="00000009 - Disclosure - Discontinued Operations"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/ForeignCurrencyRemeasurement" xlink:title="00000010 - Disclosure - Foreign Currency Remeasurement"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/EquipmentAndFurnishings" xlink:title="00000011 - Disclosure - Equipment and Furnishings"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/AccruedExpensesAndOtherCurrentLiabilities" xlink:title="00000012 - Disclosure - Accrued Expenses and Other Current Liabilities"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/Leases" xlink:title="00000013 - Disclosure - Leases"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/CommitmentsAndContingencies" xlink:title="00000014 - Disclosure - Commitments and Contingencies"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/EquityTransactions" xlink:title="00000015 - Disclosure - Equity Transactions"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants" xlink:title="00000016 - Disclosure - Stock Options and Equity-Classified Warrants"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/StockholderProtectionRightsPlan" xlink:title="00000017 - Disclosure - Stockholder Protection Rights Plan"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/IncomeTaxes" xlink:title="00000018 - Disclosure - Income Taxes"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/SubsequentEvents" xlink:title="00000019 - Disclosure - Subsequent Events"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/SummaryOfSignificantAccountingPoliciesPolicies" xlink:title="00000020 - Disclosure - Summary of Significant Accounting Policies (Policies)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/SummaryOfSignificantAccountingPoliciesTables" xlink:title="00000021 - Disclosure - Summary of Significant Accounting Policies (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/DiscontinuedOperationsTables" xlink:title="00000022 - Disclosure - Discontinued Operations (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/EquipmentAndFurnishingsTables" xlink:title="00000023 - Disclosure - Equipment and Furnishings (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/AccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:title="00000024 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/LeasesTables" xlink:title="00000025 - Disclosure - Leases (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/CommitmentsAndContingenciesTables" xlink:title="00000026 - Disclosure - Commitments and Contingencies (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrantsTables" xlink:title="00000027 - Disclosure - Stock Options and Equity-Classified Warrants (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/IncomeTaxesTables" xlink:title="00000028 - Disclosure - Income Taxes (Tables)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/NatureOfBusinessDetailsNarrative" xlink:title="00000029 - Disclosure - Nature of Business (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/SummaryOfSignificantAccountingPoliciesDetailsNarrative" xlink:title="00000030 - Disclosure - Summary of Significant Accounting Policies (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/SummaryOfSignificantAccountingPolicies-ScheduleOfFairValueMeasurementsByLevelForAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="00000031 - Disclosure - Summary of Significant Accounting Policies - Schedule of Fair Value Measurements by Level for Assets and Liabilities Measured at Fair Value on a Recurring Basis (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/DiscontinuedOperationsDetailsNarrative" xlink:title="00000032 - Disclosure - Discontinued Operations (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/DiscontinuedOperations-ScheduleOfDiscontinuedOperationsDetails" xlink:title="00000033 - Disclosure - Discontinued Operations - Schedule of Discontinued Operations (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/ForeignCurrencyRemeasurementDetailsNarrative" xlink:title="00000034 - Disclosure - Foreign Currency Remeasurement (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/EquipmentAndFurnishingsDetailsNarrative" xlink:title="00000035 - Disclosure - Equipment and Furnishings (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/EquipmentAndFurnishings-ScheduleOfEquipmentAndFurnishingsDetails" xlink:title="00000036 - Disclosure - Equipment and Furnishings - Schedule of Equipment and Furnishings (Details)">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/AccruedExpensesAndOtherCurrentLiabilities-ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:title="00000037 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="loc_us-gaapAccruedProfessionalFeesCurrent"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedProfessionalFeesCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="cytr-20191231.xsd#CYTR_AccruedResearchAndDevelopmentCosts" xlink:label="loc_CYTRAccruedResearchAndDevelopmentCosts"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_CYTRAccruedResearchAndDevelopmentCosts" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_AccruedRoyaltiesCurrent" xlink:label="loc_us-gaapAccruedRoyaltiesCurrent"/>

<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccruedRoyaltiesCurrent" xlink:type="arc" weight="1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/LeasesDetailsNarrative" xlink:title="00000038 - Disclosure - Leases (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/Leases-ScheduleOfRentExpenseAndSupplementalCashFlowInformationRelatedToLeasesDetails" xlink:title="00000039 - Disclosure - Leases - Schedule of Rent Expense and Supplemental Cash Flow Information Related to Leases (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/CommitmentsAndContingenciesDetailsNarrative" xlink:title="00000040 - Disclosure - Commitments and Contingencies (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/CommitmentsAndContingencies-ScheduleOfCurrentContractualObligationsDetails" xlink:title="00000041 - Disclosure - Commitments and Contingencies - Schedule of Current Contractual Obligations (Details)">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDue" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueCurrent" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInTwoYears" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInThreeYears" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears"/>

<link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFourYears" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears"/>

<link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueInFiveYears" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:label="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueThereafter"/>

<link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDue" xlink:to="loc_us-gaapOperatingLeasesFutureMinimumPaymentsDueThereafter" xlink:type="arc" weight="1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/EquityTransactionsDetailsNarrative" xlink:title="00000042 - Disclosure - Equity Transactions (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrantsDetailsNarrative" xlink:title="00000043 - Disclosure - Stock Options and Equity-Classified Warrants (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfShare-basedPaymentAwardFairValueOfStockOptionsGrantedAssumptionsDetails" xlink:title="00000044 - Disclosure - Stock Options and Equity-Classified Warrants - Schedule of Share-based Payment Award, Fair Value of the Stock Options Granted, Assumptions (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfShare-basedCompensationStockOptionsActivityDetails" xlink:title="00000045 - Disclosure - Stock Options and Equity-Classified Warrants - Schedule of Share-based Compensation, Stock Options, Activity (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfRangesOfStockOptionsDetails" xlink:title="00000046 - Disclosure - Stock Options and Equity-Classified Warrants - Schedule of Ranges of Stock Options (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfTotalStock-basedCompensationExpenseFromStockOptionsDetails" xlink:title="00000047 - Disclosure - Stock Options and Equity-Classified Warrants - Schedule of Total Stock-based Compensation Expense from Stock Options (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfWarrantsActivityAndRelatedInformationDetails" xlink:title="00000048 - Disclosure - Stock Options and Equity-Classified Warrants - Schedule of Warrants Activity and Related Information (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/StockOptionsAndEquity-classifiedWarrants-ScheduleOfRangesOfWarrantsDetails" xlink:title="00000049 - Disclosure - Stock Options and Equity-Classified Warrants - Schedule of Ranges of Warrants (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/StockholderProtectionRightsPlanDetailsNarrative" xlink:title="00000050 - Disclosure - Stockholder Protection Rights Plan (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/IncomeTaxesDetailsNarrative" xlink:title="00000051 - Disclosure - Income Taxes (Details Narrative)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/IncomeTaxes-ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="00000052 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)">

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment"/>

<link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsPropertyPlantAndEquipment" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilities"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:type="arc" weight="-1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="loc_us-gaapDeferredTaxAssetsLiabilitiesNet"/>

<link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" weight="1"/>

<link:loc xlink:type="locator" xlink:href="http://xbrl.fasb.org/us-gaap/2019/elts/us-gaap-2019-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance"/>

<link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsLiabilitiesNet" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="-1"/>

</link:calculationLink>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/IncomeTaxes-ScheduleOfEffectiveIncomeTaxRateReconciliationDetails" xlink:title="00000053 - Disclosure - Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details)"/>

<link:calculationLink xlink:type="extended" xlink:role="http://cytrx.com/role/SubsequentEventsDetailsNarrative" xlink:title="00000054 - Disclosure - Subsequent Events (Details Narrative)"/>

</link:linkbase>

1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/23/20  LadRx Corp.                       S-8        10/23/20    5:265K                                   M2 Compliance LLC/FA

↑Top

Filing Submission 0001493152-20-004848 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Cytrx Corp – ‘10-K’ for 12/31/19 – ‘EX-101.CAL’

On: Friday, 3/27/20, at 6:21am ET · For: 12/31/19 · Accession #: 1493152-20-4848 · File #: 0-15327

Previous ‘10-K’: ‘10-K’ on 3/29/19 for 12/31/18 · Next: ‘10-K’ on 3/24/21 for 12/31/20 · Latest: ‘10-K’ on 3/27/24 for 12/31/23 · 1 Reference: By: LadRx Corp. – ‘S-8’ on 10/23/20

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34Filing Table of Contents

‘EX-101.CAL’ — XBRL Calculations — cytr-20191231_cal

This Exhibit is an XBRL XML File.

1 Subsequent Filing that References this Filing

Annual Report — Form 10-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents